Bahrain : The National Health Regulatory Authority (NHRA) has approved the emergency use of the VLA2001 COVID-19 vaccine produced by the European vaccine company, Valneva.
The vaccine has been approved for ages 18 years and above, making it the seventh vaccine to be authorized for emergency use in the Kingdom of Bahrain, as part of Bahrain’s efforts to combat the COVID-19.
The NHRA’s approval is based on the Authority’s Clinical Research Committee and the Ministry of Health Vaccination Committee’s in-depth study of all documents submitted by the company, which included the results of the immunology study. All documents related to the clinical study of the vaccine were reviewed and revealed positive results in preventing the virus.
The NHRA explained that the Ministry of Health will start the importation procedures in accordance with the standards and special requirements based on the approval issued today.
